Kirstin I. Oliveira Roster

Kirstin I. Oliveira Roster

Auto-generated profile, based on publicly available information

Kirstin I. Oliveira Roster

Harvard School of Public Health

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017
Verified
Book
Closed access
MCMatthieu Cristelli
Matthieu Cristelli
ATAndrea Tacchella
Andrea Tacchella
MCMasud Cader
Masud Cader
KRKirstin Roster
Kirstin Roster
LPLuciano Pietronero
Luciano Pietronero

26 December 2024 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
KRKirstin Oliveira Roster
Kirstin Oliveira Roster
TMTiago Martinelli
Tiago Martinelli
CCColm Connaughton
Colm Connaughton
MSMauricio Santillana
Mauricio Santillana
FRFrancisco A Rodrigues
Francisco A Rodrigues
Measures to curb the spread of SARS-CoV-2 impacted not only COVID-19 dynamics, but also other infectious diseases, such as dengue in Brazil. The COVID-19 pandemic disrupted not only transmission dynamics due to changes in mobility patterns, but also several aspects of surveillance, such as care seeking behavior and clinical capacity. However, we lack a clear understanding of the overall impact on dengue in different parts of Brazil and the contribution of individual causal drivers. In this study, we estimated the gap between expected and observed dengue cases in each Brazilian state from March to April 2020 using an interrupted time series design with forecasts from machine learning models. We then decomposed the gap into the contributions of pandemic-induced changes in disease surveillance and transmission dynamics, using proxies for care availability and care seeking behavior. Of 25 states in the analysis, 19 reported fewer dengue cases than predicted and the gap between expected and observed cases was largely explained by excess under-reporting, as illustrated by a reduction in observed cases below expected levels in early March 2020 in several states. A notable exception is the experience in the Southern states, which reported unusually large dengue outbreaks in 2020. These estimates of dengue case counts adjusted for under-reporting help mitigate some of the data gaps from 2020. Reliable estimates of changes in the disease burden are critical for anticipating future outbreaks.

5 September 2024 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
KRKirstin I. Oliveira Roster
Kirstin I. Oliveira Roster
SKStephen M. Kissler
Stephen M. Kissler
EOEnoma Omoregie
Enoma Omoregie
JWJade C. Wang
Jade C. Wang
HAHelly Amin
Helly Amin
YGYonatan H. Grad
Yonatan H. Grad
Surveillance systems that monitor pathogen genome sequences are critical for rapidly detecting the introduction and emergence of pathogen variants. To evaluate how interactions between surveillance capacity, variant properties, and the epidemiological context influence the timeliness of pathogen variant detection, we developed a geographically explicit stochastic compartmental model to simulate the transmission of a novel SARS-CoV-2 variant in New York City. We measured the impact of (1) testing and sequencing volume, (2) geographic targeting of testing, (3) the timing and location of variant emergence, and (4) the relative variant transmissibility on detection speed and on the undetected disease burden. Improvements in detection times and reduction of undetected infections were driven primarily by increases in the number of sequenced samples. The relative transmissibility of the new variant and the epidemic context of variant emergence also influenced detection times, showing that individual surveillance strategies can result in a wide range of detection outcomes, depending on the underlying dynamics of the circulating variants. These findings help contextualize the design, interpretation, and trade-offs of genomic surveillance strategies of pandemic respiratory pathogens.

23 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
KRKirstin I. Oliveira Roster
Kirstin I. Oliveira Roster
YGYonatan H. Grad
Yonatan H. Grad
Doxycycline as post-exposure prophylaxis (doxy-PEP) reduces the risk of gonorrhea, chlamydia, and syphilis in studies of men who have sex with men (MSM) and transgender women (TGW) on HIV Pre-exposure Prophylaxis (PrEP) and people living with HIV (PLWH)). Doxy-PEP is an important tool to address the increasing burden of sexually transmitted infections (STIs), but there is concern that increased consumption of doxycycline may drive antimicrobial resistance. We estimated the expected increase in antibiotic use in the US under several doxy-PEP prescribing scenarios. We accounted for doses of antibiotics that may be averted due to the prevention of chlamydia, gonorrhea, and syphilis infections by doxy-PEP. Under a scenario of 75% adoption among the eligible population, with rates of consumption similar to the DoxyPEP trial population, monthly antibiotic consumption would increase by around 2.52 million doses, driven by doxy-PEP consumption of 2.58 million doses and less 62.1 thousand antibiotic doses that would otherwise have been used for chlamydia, gonorrhea, and syphilis treatment.

18 December 2025 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
KRKirstin I Oliveira Roster
Kirstin I Oliveira Roster
PWPeter J White
Peter J White
YGYonatan H Grad
Yonatan H Grad
After nearly a decade of rising gonorrhea rates, the US Centers for Disease Control and Prevention (CDC) reported a decline in infection rates for 2 years in a row in 2022 and 2023, especially among young adults. While this warrants cautious optimism that control measures have been successful, the reasons for the decline are unknown. We do not know what lessons can be learned about the 4CMenB vaccine with partial protection against gonorrhea, doxycycline postexposure prophylaxis (doxy-PEP), asymptomatic screening, sexual behavior, or other possible drivers. Here, we enumerate potential drivers of the decline in gonorrhea, the evidence that argues for or against each one, and the data needed to clarify their roles. We hope to encourage those with suitable data to perform the analyses we outline, for surveillance systems to provide more detailed data where possible, and for existing and new surveillance and research studies to collect additional data.

9 February 2023 in Research Square
Verified
Preprint
Open access
PDF file
KRKirstin Oliveira Roster
Kirstin Oliveira Roster
TMTiago Martinelli
Tiago Martinelli
CCColm Connaughton
Colm Connaughton
MSMauricio Santillana
Mauricio Santillana
FRFrancisco Rodrigues
Francisco Rodrigues
Atypical dengue prevalence was observed in 2020 in many dengue-endemic countries, including Brazil. Evidence suggests that the pandemic disrupted not only dengue dynamics due to changes in mobility patterns, but also several aspects of dengue surveillance, such as care seeking behavior, care availability, and monitoring systems. However, we lack a clear understanding of the overall impact on dengue in different parts of the country as well as the role of individual causal drivers. In this study, we estimated the gap between expected and observed dengue cases in 2020 using an interrupted time series design with forecasts from a neural network and a structural Bayesian time series model. We also decomposed the gap into the impacts of climate conditions, pandemic-induced changes in reporting, human susceptibility, and human mobility. We find that there is considerable variation across the country in both overall pandemic impact on dengue and the relative importance of individual drivers. Increased understanding of the causal mechanisms driving the 2020 dengue season helps mitigate some of the data gaps caused by the COVID-19 pandemic and is critical to developing effective public health interventions to control dengue in the future.